Search research articles
Contact Us
Filters
Showing results (261-270 of 294) with videos related to
Page
of 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2001
WWOX: a candidate tumor suppressor gene involved in multiple tumor types
A J Paige, K J Taylor, C Taylor, et al.
Cancer Research
|
June 26, 1999
Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer
K C Connolly, H Gabra, C J Millwater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen
S P Langdon, H Gabra, J M Bartlett, et al.
International Journal of Cancer
|
June 15, 1987
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient
C R Wolf, I P Hayward, S S Lawrie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2001
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report
B Coudert, A Anthoney, W Fiedler, et al.
Annals of Surgical Oncology
|
April 15, 2006
Implication of the BRCA2 and putative "BRCA3" genes in Dukes' stage C, replication error-negative colon cancer
Nala S Sivarajasingham, Lynn Cawkwell, Richard P Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors
Miguel A Izquierdo, Angela Bowman, Margarita García, et al.
The British Journal of Surgery
|
September 1, 1984
Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C
D Cunningham, M Soukop, C S McArdle, et al.
Cancer Research
|
November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell lines
S P Langdon, S S Lawrie, F G Hay, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 294) with videos related to
Sort By:
Page
of 30
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2001
WWOX: a candidate tumor suppressor gene involved in multiple tumor types
A J Paige, K J Taylor, C Taylor, et al.
Cancer Research
|
June 26, 1999
Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer
K C Connolly, H Gabra, C J Millwater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen
S P Langdon, H Gabra, J M Bartlett, et al.
International Journal of Cancer
|
June 15, 1987
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient
C R Wolf, I P Hayward, S S Lawrie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2001
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report
B Coudert, A Anthoney, W Fiedler, et al.
Annals of Surgical Oncology
|
April 15, 2006
Implication of the BRCA2 and putative "BRCA3" genes in Dukes' stage C, replication error-negative colon cancer
Nala S Sivarajasingham, Lynn Cawkwell, Richard P Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors
Miguel A Izquierdo, Angela Bowman, Margarita García, et al.
The British Journal of Surgery
|
September 1, 1984
Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C
D Cunningham, M Soukop, C S McArdle, et al.
Cancer Research
|
November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell lines
S P Langdon, S S Lawrie, F G Hay, et al.
Page
of 30